Related Experiment Video
Updated: Jun 21, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Limitations of using citrulline levels as a marker of gastrointestinal function in patients with chronic intestinal
Karolina Goral1, Przemysław Matras2
1Department of Clinical Nutrition, Medical University of Lublin, ul, Jaczewskiego 8, Lublin, 20-090, Poland; Clinical Nutrition Center, University Clinical Hospital No. 4 ul, Jaczewskiego 8, Lublin, 20-090, Poland.
Background And Aims:
Citrulline (CIT), produced almost exclusively by enterocytes, is a potentially sensitive biomarker of small intestine absorptive function in patients with chronic intestinal failure (CIF). The aim of this study was to evaluate the utility and limitations of plasma citrulline (CIT) level measurements in assessing gastrointestinal function in patients with chronic intestinal failure (CIF), including a comparison between patients with and without cancer.
Methods:
The study was conducted among 56 CIF patients. The study of the profile of plasma CIT was performed by tandem mass spectrometry (LC-MS/MS) technique. The retrospective data analysis has included the average weekly volume of parenteral nutrition mixture (ml), average weekly volume of intravenous fluid and electrolyte infusions, duration of HPN, energy (kcal) and amino acids (g), and analysis of medical history. Body composition testing was performed with a Tanita MC-780 S MA body composition analyzer.
Results:
Analyses showed that individuals without active cancer (M = 20.94; SD = 10.55) had significantly higher plasma CIT levels compared to the group with active cancer (M = 14.77; SD = 7.26). There were no statistically significant differences in CIT levels (p = 0.466) among the three subgroups of SBS patients. No correlation was found between plasma citrulline levels and the duration of parenteral nutrition, nitrogen dose in the parenteral solution, energy requirements, intravenous fluid and electrolyte needs, or nutritional status.
Conclusions:
Plasma citrulline level is not a useful biomarker of intestinal adaptation in the group of subjects with CIF. Long-term multicenter studies are necessary to assess the usefulness of CIT in evaluating gastrointestinal function in CIF.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

